Effect of human urotensin-II infusion on hemodynamics and cardiac function
- PMID: 12710525
- DOI: 10.1139/y03-004
Effect of human urotensin-II infusion on hemodynamics and cardiac function
Abstract
Recent studies have shown that the vasoactive peptide urotensin-II (U-II) exerts a wide range of action on the cardiovascular system of various species. In the present study, we determined the in vivo effects of U-II on basal hemodynamics and cardiac function in the anesthetized intact rat. Intravenous bolus injection of human U-II resulted in a dose-dependent decrease in mean arterial pressure and left ventricular systolic pressure. Cardiac contractility represented by +/-dP/dt was decreased after injection of U-II. However, there was no significant change in heart rate or diastolic pressure. The present study suggests that upregulation of myocardial U-II may contribute to impaired myocardial function in disease conditions such as congestive heart failure.
Similar articles
-
Urotensin II stimulates high frequency-induced ANP secretion via PLC-PI 3K-PKC pathway.Peptides. 2010 Jan;31(1):164-9. doi: 10.1016/j.peptides.2009.10.020. Epub 2009 Nov 5. Peptides. 2010. PMID: 19896516
-
Aortic peak flow velocity as an index of myocardial contractility in the conscious rat.Methods Find Exp Clin Pharmacol. 1997 Oct;19(8):533-9. Methods Find Exp Clin Pharmacol. 1997. PMID: 9442476
-
Renal effects of human urotensin-II in rats with experimental congestive heart failure.Nephrol Dial Transplant. 2006 May;21(5):1205-11. doi: 10.1093/ndt/gfk049. Epub 2006 Jan 5. Nephrol Dial Transplant. 2006. PMID: 16396970
-
Cardiovascular role of urotensin II: effect of chronic infusion in the rat.Peptides. 2004 Oct;25(10):1783-8. doi: 10.1016/j.peptides.2004.03.029. Peptides. 2004. PMID: 15476946 Review.
-
Urotensin II: a cardiovascular and renal update.Curr Opin Nephrol Hypertens. 2008 Mar;17(2):199-204. doi: 10.1097/MNH.0b013e3282f49566. Curr Opin Nephrol Hypertens. 2008. PMID: 18277155 Review.
Cited by
-
Urotensin II acutely increases myocardial length and distensibility: potential implications for diastolic function and ventricular remodeling.Naunyn Schmiedebergs Arch Pharmacol. 2007 Oct;376(1-2):107-15. doi: 10.1007/s00210-007-0180-8. Epub 2007 Aug 14. Naunyn Schmiedebergs Arch Pharmacol. 2007. PMID: 17701026
-
Impact of Classic Adrenal Secretagogues on mRNA Levels of Urotensin II and Its Receptor in Adrenal Gland of Rats.Int J Mol Sci. 2023 Aug 29;24(17):13412. doi: 10.3390/ijms241713412. Int J Mol Sci. 2023. PMID: 37686217 Free PMC article.
-
Discovery of new antagonists aimed at discriminating UII and URP-mediated biological activities: insight into UII and URP receptor activation.Br J Pharmacol. 2013 Feb;168(4):807-21. doi: 10.1111/j.1476-5381.2012.02217.x. Br J Pharmacol. 2013. PMID: 22994258 Free PMC article.
-
A closer look at the role of urotensin II in the metabolic syndrome.Front Endocrinol (Lausanne). 2012 Dec 28;3:165. doi: 10.3389/fendo.2012.00165. eCollection 2012. Front Endocrinol (Lausanne). 2012. PMID: 23293629 Free PMC article.
-
Potential Clinical Implications of the Urotensin II Receptor Antagonists.Front Pharmacol. 2011 Jul 22;2:38. doi: 10.3389/fphar.2011.00038. eCollection 2011. Front Pharmacol. 2011. PMID: 21811463 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources